L V Boyer

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom
    L V Boyer
    Department of Pediatrics and Arizona Poison and Drug Information Center, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Ann Emerg Med 37:196-201. 2001
  2. ncbi Antivenom for critically ill children with neurotoxicity from scorpion stings
    Leslie V Boyer
    VIPER Institute, University of Arizona Health Sciences Center, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA
    N Engl J Med 360:2090-8. 2009
  3. ncbi Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies
    S A Seifert
    Arizona Poison and Drug Information Center, and the Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Ann Emerg Med 37:189-95. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom
    L V Boyer
    Department of Pediatrics and Arizona Poison and Drug Information Center, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Ann Emerg Med 37:196-201. 2001
    ..Duration of therapy depends on individual risk factors and coagulation response...
  2. ncbi Antivenom for critically ill children with neurotoxicity from scorpion stings
    Leslie V Boyer
    VIPER Institute, University of Arizona Health Sciences Center, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA
    N Engl J Med 360:2090-8. 2009
    ..We hypothesized that a scorpion-specific F(ab')(2) antivenom would promptly resolve clinical symptoms in children with this syndrome...
  3. ncbi Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies
    S A Seifert
    Arizona Poison and Drug Information Center, and the Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Ann Emerg Med 37:189-95. 2001
    ..Understanding the relative kinetics and dynamics of immunoglobulins and their targets may allow the physician to anticipate their clinical implications and may suggest modifications of the drug or dose to produce better clinical results...